Drug Detail:Formoterol and mometasone (Formoterol and mometasone [ for-moe-ter-ol-and-moe-met-a-sone ])
Drug Class: Bronchodilator combinations
Usual Adult Dose for Asthma - Maintenance
5 to 11 years: 2 inhalations of 50 mcg mometasone/5 mcg formoterol twice a day
Maximum dose: 200 mcg mometasone/20 mcg formoterol per day
12 years and older: Two inhalations twice daily (morning and evening).
- Each inhalation contains either 100 mcg or 200 mcg of mometasone with 5 mcg of formoterol.
Comments:
- The starting dose should be determined based on patient's previous asthma therapy.
- Patients previously on inhaled medium dose corticosteroids should be started on the 100 mcg/5 mcg strength.
- Patients previously on inhaled high dose corticosteroids should be started on the 200 mcg/5 mcg strength.
- Not for use in treatment of acute bronchospasm.
Usual Pediatric Dose for Asthma - Maintenance
For children 12 years of age and older:
Two inhalations inhaled orally twice daily (morning and evening).
Each inhalation contains either 100 mcg or 200 mcg of mometasone with 5 mcg of formoterol.
Maximum Daily Dose: 800 mcg of mometasone; 20 mcg of formoterol
Comments:
- The starting dose should be determined based on patient's previous asthma therapy.
- Patients previously on inhaled medium dose corticosteroids should be started on the 100 mcg/5 mcg strength.
- Patients previously on inhaled high dose corticosteroids should be started on the 200 mcg/5 mcg strength.
- Not for use in treatment of acute bronchospasm.
Use: Indicated for patients 12 years of age and older who have inadequate control on a long-term asthma control medication or whose disease severity requires initiation of an inhaled corticosteroid and long-acting beta2-adrenergic agonist
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
CONTRAINDICATIONS:
- Status asthmaticus or other acute asthma episodes requiring intensive measures
- Hypersensitivity to any of the ingredients
Safety and efficacy have not been established in patients younger than 5 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- Rinse mouth with water without swallowing after use.
- The inhaler should be primed before using for the first time and/or if not used for more than 5 days by releasing 4 test sprays into the air, away from the face, and shaking well before each spray.
- Shake well prior to each inhalation.
- Remove the cap from the mouthpiece of the actuator before using.
Storage requirements:
- Canister should remain in actuator to ensure delivery of correct amount of medication and proper functioning of the dose counter.
- Store the 60-inhalation inhaler with mouthpiece down or in a horizontal position.
Monitoring:
- Hepatic: Monitor patients for signs of increased drug exposure.
- Immunologic: Monitor for signs of development of oral candidiasis.
- Musculoskeletal: Monitor bone mineral density (BMD) in patients at higher risk for decreased BMD.
- Musculoskeletal: Monitor growth of pediatric patients.